EA018775B1 - Применение тестостерона в форме водно-спиртового геля для лечения детского гипогонадизма - Google Patents

Применение тестостерона в форме водно-спиртового геля для лечения детского гипогонадизма Download PDF

Info

Publication number
EA018775B1
EA018775B1 EA200901288A EA200901288A EA018775B1 EA 018775 B1 EA018775 B1 EA 018775B1 EA 200901288 A EA200901288 A EA 200901288A EA 200901288 A EA200901288 A EA 200901288A EA 018775 B1 EA018775 B1 EA 018775B1
Authority
EA
Eurasian Patent Office
Prior art keywords
testosterone
gel
age
use according
hydroalcoholic gel
Prior art date
Application number
EA200901288A
Other languages
English (en)
Russian (ru)
Other versions
EA200901288A1 (ru
Inventor
Роберт И. Дадли
Алан Д. Рогол
Джэнет Бенеш
Трой Л. Замбруннен
Грэг Прэтт
Джон Дж. Бреннан
Хжалмар Лагаст
Original Assignee
Юнимед Фармасьютикалз Ллк
Лаборатуар Безен Энтернасьональ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Юнимед Фармасьютикалз Ллк, Лаборатуар Безен Энтернасьональ filed Critical Юнимед Фармасьютикалз Ллк
Publication of EA200901288A1 publication Critical patent/EA200901288A1/ru
Publication of EA018775B1 publication Critical patent/EA018775B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
EA200901288A 2007-03-23 2008-03-20 Применение тестостерона в форме водно-спиртового геля для лечения детского гипогонадизма EA018775B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07104726 2007-03-23
PCT/EP2008/053372 WO2008116825A2 (en) 2007-03-23 2008-03-20 Compositions and method for treating pediatric hypogonadism

Publications (2)

Publication Number Publication Date
EA200901288A1 EA200901288A1 (ru) 2010-04-30
EA018775B1 true EA018775B1 (ru) 2013-10-30

Family

ID=38321980

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200901288A EA018775B1 (ru) 2007-03-23 2008-03-20 Применение тестостерона в форме водно-спиртового геля для лечения детского гипогонадизма

Country Status (10)

Country Link
EP (1) EP2136813A2 (cg-RX-API-DMAC7.html)
JP (1) JP2010521519A (cg-RX-API-DMAC7.html)
CN (1) CN101754764A (cg-RX-API-DMAC7.html)
AU (1) AU2008231781B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0809124A8 (cg-RX-API-DMAC7.html)
CA (1) CA2623477C (cg-RX-API-DMAC7.html)
EA (1) EA018775B1 (cg-RX-API-DMAC7.html)
IL (1) IL200887A0 (cg-RX-API-DMAC7.html)
MX (1) MX2009008995A (cg-RX-API-DMAC7.html)
WO (1) WO2008116825A2 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO3755B1 (ar) * 2011-01-26 2021-01-31 Ferring Bv تركيبات تستوستيرون
MX2013013369A (es) * 2011-05-15 2014-10-17 Trimel Biopharma Srl Formulaciones de gel bioadhesivo de testosterona intranasal y uso del mismo para tratar hipogonadismo masculino.

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002017926A1 (en) * 2000-08-30 2002-03-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
US20040072810A1 (en) * 2001-11-07 2004-04-15 Besins International Belgique Pharmaceutical composition in the form of a gel or a solution based on dihydrotestosterone, process for preparing it and uses thereof
WO2004037173A2 (en) * 2002-10-18 2004-05-06 Unimed Pharmaceuticals, Inc. Method for treating erectile dysfunction and increasing libido in men
WO2005076899A2 (en) * 2004-02-09 2005-08-25 University Of Washington Oral androgen therapy using modulators of testosterone bioavailablity
WO2007044976A2 (en) * 2005-10-12 2007-04-19 Unimed Pharmaceuticals, Llc Improved testosterone gel and method of use

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002017926A1 (en) * 2000-08-30 2002-03-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
US20040072810A1 (en) * 2001-11-07 2004-04-15 Besins International Belgique Pharmaceutical composition in the form of a gel or a solution based on dihydrotestosterone, process for preparing it and uses thereof
WO2004037173A2 (en) * 2002-10-18 2004-05-06 Unimed Pharmaceuticals, Inc. Method for treating erectile dysfunction and increasing libido in men
WO2005076899A2 (en) * 2004-02-09 2005-08-25 University Of Washington Oral androgen therapy using modulators of testosterone bioavailablity
WO2007044976A2 (en) * 2005-10-12 2007-04-19 Unimed Pharmaceuticals, Llc Improved testosterone gel and method of use

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
ARISAKA O. ET AL.: "Systemic effects of transdermal testosterone for the treatment of microphallus in children." PEDIATRICS INTERNATIONAL: OFFICIAL JOURNAL OF THE JAPAN-PEDIATRIC SOCIETY APR 2001, vol. 43, no. 2, April 2001 (2001-04), pages 134-136, XP008082233, ISSN: 1328-8067, page 134, column 1 - column 2 *
DROBAC S. ET AL.: "A Workshop on pubertal hormone replacement options in the United States", JOURNAL OF PEDIATRIC ENDOCRINOLOGY AND METABOLISM 2006 ISRAEL, vol. 19, no. 1, 2006, pages 55-64, XP008082229, ISSN: 0334-018X, page 58, column 2, paragraph 2 - paragraph 4, page 60, column 1, paragraph 2, page 62 *
MATSUMOTO A. M.: "Hormonal therapy of male hypogonadism", ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA 1994 UNITED STATES, vol. 23, no. 4, 1994, pages 857-875, XP008082230, ISSN: 0889-8529, page 873, paragraph 2 - paragraph 3, table 1 *
RICHMOND E. J. ET AL.: "Male pubertal development and the role of androgen therapy", NATURE CLINICAL PRACTICE ENDOCRINOLOGY AND METABOLISM 2007 UNITED KINGDOM, vol. 3, no. 4, April 2007 (2007-04), pages 338-344, XP008082235, ISSN: 1745-8366 1745-8374, page 341, column 1, paragraph 2, page 341, column 2, paragraph 5, page 342, column 1, paragraph 2 *
ROGOL A. D.: "New facets of androgen replacement therapy during childhood and adolescence", EXPERT OPINION ON PHARMACOTHERAPY 2005, UNITED KINGDOM, vol. 6, no. 8, 2005, pages 1319-1336, XP008082228, ISSN: 1465-6566, table 1, page 1327, column 2, paragraph 4, page 1328, column 1, page 1329, column 2, paragraph 3, page 1332, column 2, paragraph 3 *

Also Published As

Publication number Publication date
BRPI0809124A8 (pt) 2015-11-24
EA200901288A1 (ru) 2010-04-30
CA2623477C (en) 2011-05-31
MX2009008995A (es) 2009-09-03
AU2008231781A1 (en) 2008-10-02
EP2136813A2 (en) 2009-12-30
WO2008116825A3 (en) 2008-11-27
IL200887A0 (en) 2010-05-17
AU2008231781B2 (en) 2012-09-20
WO2008116825A2 (en) 2008-10-02
JP2010521519A (ja) 2010-06-24
CA2623477A1 (en) 2008-09-23
BRPI0809124A2 (pt) 2014-08-26
CN101754764A (zh) 2010-06-23

Similar Documents

Publication Publication Date Title
US8466136B2 (en) Testosterone gel and method of use
EP2667851B1 (en) Testosterone formulations
US20060211664A1 (en) Method for treating erectile dysfunction and increasing libido in men
US20080261937A1 (en) Pharmaceutical compositions and method for treating pediatric hypogonadism
IL186356A (en) Transdermal hydraulic alcohol gel preparation for use in the treatment of type 2 diabetes
CA2623477C (en) Compositions and method for treating pediatric hypogonadism
HK1227768A (en) Testosterone formulations
HK1227768A1 (en) Testosterone formulations
NZ613029B (en) Testosterone formulations
HK1192719B (en) Testosterone formulations

Legal Events

Date Code Title Description
PC4A Registration of transfer of a eurasian patent by assignment